Stada Arzneimittel AG has begun talking to potential buyers as the German generic-drug maker’s owners pursue a possible sale that could value the company at about €8 billion ($8.7 billion), people with knowledge of the matter said. The early-stage suitors include Clayton Dubilier & Rice, CVC Capital and KKR & Co., the people said, declining to be identified because the information is private. Other firms looking at the business include GTCR, Canada Pension Plan Investment Board, Asia-based investment firm Hillhouse, Nordic Capital and Koch Industries, some of them said.
Read the full article: Drugmaker Stada Said to Talk to Buyout Firms in €8B Sale //
Source: https://www.bloomberg.com/news/articles/2024-04-09/drugmaker-stada-said-to-talk-to-buyout-firms-in-8-billion-sale